T细胞受体疗法触发了实验性脑膜炎的自我调节
H Offner1, G A Hashim, A A Vandenbark
1Neuroimmunology Research, Veterans Administration Medical Center, Portland, OR.
概括
合成T细胞受体 (TCR) ,特别是TCR-Vβ8-39-59,可以治疗大鼠的实验性自身免疫脑炎 (EAE). 这种疗法减少了疾病的严重程度,并通过增强对疾病的自然免疫反应来促进恢复.
科学领域:
- 神经免疫学 神经免疫学
- 免疫治疗是一种免疫疗法.
- 自身免疫性疾病是一种自身免疫性疾病.
背景情况:
- 针对髓基蛋白的脑性T细胞利用特定的T细胞受体 (TCR) Vβ8序列.
- 这些TCR序列可以诱导调节性T细胞和预防实验性自身免疫脑炎 (EAE) 的抗体.
- 在治疗已确定的EAE方面,TCR的治疗潜力仍然未被探索.
研究的目的:
- 在已建立的EAE中研究TCR的治疗效果.
- 为了确定TCR-Vβ8-39-59的使用是否可以改善EAE的临床症状.
主要方法:
- 呈现EAE临床症状的老鼠用合成TCR-Vβ8-39-59进行了治疗.
- 在治疗后监测疾病严重程度和康复率.
主要成果:
- 用TCR-Vβ8-39-59治疗显著降低了EAE疾病的严重程度.
- 的施用加速了EAE的临床症状的恢复.
- 治疗效果归因于增强抗Vβ8T细胞和抗体.
结论:
- 合成的TCR表明治疗潜在的治疗已建立的自身免疫性疾病,如EAE.
- 该TCR-Vβ8-39-59序列作为一个自然的白痴,促进EAE恢复.
- 人类TCR可能提供一种新的方法来增强自身反应性T细胞在自身免疫条件下的自然调节.
相关概念视频
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...


